The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in rheumatologic disorders: A comprehensive review

Rheumatology International

Volumn 32, Issue 2, 2012, Pages 287-294

  Mihos, Christos G ^a   Artola, Rosa T ^b   Santana, Orlando ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Hydroxy methyl glutaryl CoA; Inhibitors; Pleiotropic; Reductase; Rheumatic diseases; Statins

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PLACEBO; ROSUVASTATIN;

ANTIPHOSPHOLIPID SYNDROME; ATHEROSCLEROSIS; HUMAN; NONHUMAN; OSTEOARTHRITIS; OSTEOPOROSIS; PLEIOTROPY; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ANIMALS; ANTIRHEUMATIC AGENTS; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; DRUG TOXICITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; OFF-LABEL USE; RHEUMATIC DISEASES;

EID: 84857047906     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2008-6     Document Type: Review

References (100)

1. M Pignone C Phillips C Mulrow 2000 Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomized trials BMJ. 321 983 985 11039962 10.1136/bmj.321.7267.983 1:CAS:528: DC%2BD3cXotV2jurc%3D
2. Tonkin A, Aylward P, Colquhoun D et al. (1998) Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The long-term intervention with pravastatin in ischaemic disease (LIPID) study group. N Engl J Med 339(19):1349-1357 (Pubitemid 28509344)
3. M Endres 2005 Statins and stroke J Cereb Blood Flow Metab 25 9 1093 1110 15815580 10.1038/sj.jcbfm.9600116 1:CAS:528:DC%2BD2MXhtVGnurjN (Pubitemid 41710736)
4. JK Liao 2002 Beyond lipid lowering: the role of statins in vascular protection Int J Cardiol 86 1 5 18 12243846 10.1016/S0167-5273(02)00195-X (Pubitemid 35247880)
5. J Li JJ Li JG He JL Nan YL Guo CM Xiong 2010 Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappa B pathway Cardiovasc Ther 28 1 8 14 20074254 10.1111/j.1755-5922.2009.00103.x 1:CAS:528:DC%2BC3cXitlWit7s%3D
6. V Tandon G Bano V Khajuria A Parihar S Gupta 2005 Pleiotropic effects of statins Indian J Pharmacol 37 2 77 85 10.4103/0253-7613.15106 1:CAS:528:DC%2BD2MXhtVOltbzP (Pubitemid 40545240)
7. S Blaschke V Viereck G Schwarz HM Klinger S Guerluek GA Müller 2009 Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis Scand J Rheumatol 38 4 235 239 19247848 10.1080/03009740802572475 1:CAS:528:DC%2BD1MXhtFCgsLvL
8. Lazzerini PE, Lorenzini S, Selvi E et al. (2007) Simvastatin inhibits cytokine production and nuclear factor-k B activation in interleukin 1-beta stimulated synoviocytes from rheumatoid arthritis patients. Clin Exp Rheumatol 25(5):696-700 (Pubitemid 350284842)
9. H Xu P Liu L Liang, et al. 2006 RhoA-mediated, tumor necrosis factor alpha-induced activation of NF-kappaB in rheumatoid synoviocytes: inhibitory effect of simvastatin Arthritis Rheum 54 11 3441 3451 17075836 10.1002/art.22169 1:CAS:528:DC%2BD28Xht12mtLnF (Pubitemid 44737156)
10. AM Connor S Berger A Narendran EC Keystone 2006 Inhibition of protein geranylgeranylation induces apoptosis in synovial fibroblasts Arthritis Res Ther 8 4 R94 16774691 10.1186/ar1968
11. T Nagashima H Okazaki K Yudoh H Matsuno S Minota 2006 Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis Arthritis Rheum 54 2 579 586 16447234 10.1002/art.21564 1:CAS:528: DC%2BD28XhvFKhsb8%3D (Pubitemid 43228634)
12. K Yokota F Miyoshi T Miyazaki, et al. 2008 High concentration simvastatin induces apoptosis in fibroblast-like synoviocytes from patients with rheumatoid arthritis J Rheumatol 35 2 193 200 18203325 1:CAS:528:DC%2BD1cXjtFamsbg%3D (Pubitemid 351281140)
13. C Tikiz O Utuk T Pirildar, et al. 2005 Effects of angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with long-term rheumatoid arthritis J Rheumatol 32 11 2095 2101 16265685 1:CAS:528:DC%2BD2MXht12ltbrK (Pubitemid 41587851)
14. Y Haruna Y Morita T Yada M Satoh DA Fox N Kashihara 2007 Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis Arthritis Rheum 56 6 1827 1835 17530711 10.1002/art.22632 1:CAS:528:DC%2BD2sXnsVOhtLY%3D (Pubitemid 47110382)
15. AR Kinderlerer R Steinberg M Johns, et al. 2006 Statin-induced expression of CD59 on vascular endothelium in hypoxia: a potential mechanism for the anti-inflammatory actions of statins in rheumatoid arthritis Arthritis Res Ther 8 4 R130 16859540 10.1186/ar2019
16. R Paumelle C Blanquart O Briand, et al. 2006 Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway Circ Res 98 3 361 369 16397146 10.1161/01.RES.0000202706.70992.95 1:CAS:528:DC%2BD28Xht1Cmurw%3D
17. Lin H, Xiao Y, Chen G et al. (2010) HMG-CoA reductase inhibitor simvastatin suppresses Toll-like receptor 2 ligand-induced activation of nuclear factor kappa B by preventing RhoA activation in monocytes from rheumatoid arthritis patients. Rheumatol Int. 15 May 2010. (in press)
18. G Weitz-Schmidt K Welzenbach V Brinkmann, et al. 2001 Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site Nat Med 7 6 687 692 11385505 10.1038/89058 1:CAS:528:DC%2BD3MXktlGkurc%3D (Pubitemid 32588024)
19. DW McCarey IB McInnes R Madhok, et al. 2004 Trial of atorvastatin in rheumatoid arthritis (TARA): double-blind, randomized placebo-controlled trial Lancet 363 9426 2015 2021 15207950 10.1016/S0140-6736(04)16449-0 1:CAS:528:DC%2BD2cXltVCitr0%3D (Pubitemid 38781100)
20. IV Shirinsky OI Zheltova NY Solovyova VA Kozlov 2009 Shirinsky versus changes in disease activity, cytokine production, and proliferation of peripheral blood mononuclear cells in patients with rheumatoid arthritis after simvastatin treatment Scand J Rheumatol 38 1 23 27 18830905 10.1080/ 03009740802363776 1:CAS:528:DC%2BD1MXhsFWntLc%3D
21. KM Mäki-Petäjä AD Booth FC Hall, et al. 2007 Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis J Am Coll Cardiol 50 9 852 858 17719471 10.1016/j.jacc.2007.04.076 (Pubitemid 47268750)
22. H Okamoto K Koizumi S Kamitsuji, et al. 2007 Beneficial action of statins in patients with rheumatoid arthritis in a large observational cohort J Rheumatol 34 5 964 968 17444591 1:CAS:528:DC%2BD2sXmtV2rt7c%3D (Pubitemid 46774839)
23. N Bansback R Ara S Ward A Anis HK Choi 2009 Statin therapy in rheumatoid arthritis: a cost-effectiveness and value-of-information analysis Pharmacoeconomics 27 1 25 37 19178122 10.2165/00019053-200927010-00004
24. G Chodick H Amital Y Shalem, et al. 2010 Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study PLoS Med 7 9 e1000336 20838658 10.1371/journal.pmed.1000336
25. SS Jick H Choi L Li IB McInnes N Sattar 2009 Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis Ann Rheum Dis 68 4 546 551 18662929 10.1136/ard.2008.091967 1:CAS:528:DC%2BD1MXkt1emt70%3D
26. P Orozco 2004 Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women Eur J Epidemiol 19 12 1105 1112 15678790 10.1007/s10654-004-1706-8 1:CAS:528:DC%2BD2MXnt1SjtQ%3D%3D (Pubitemid 40228498)
27. R Hanayama H Shimizu H Nakagami, et al. 2009 Fluvastatin improves osteoporosis in fructose-fed insulin resistant model rats through blockade of the classical mevalonate pathway and antioxidant action Int J Mol Med 23 5 581 588 19360315 1:CAS:528:DC%2BD1MXlsFWrt7w%3D
28. KS Ahn G Sethi MM Chaturvedi BB Aggarwal 2008 Simvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand through modulation of NF-kappaB pathway Int J Cancer 123 8 1733 1740 18688862 10.1002/ijc.23745 1:CAS:528:DC%2BD1cXhtFKhu7jK
29. A Staal JC Frith MH French, et al. 2003 The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity J Bone Miner Res 18 1 88 96 12510809 10.1359/jbmr.2003.18.1. 88 1:CAS:528:DC%2BD3sXltFKksg%3D%3D (Pubitemid 36008343)
30. PY Chen JS Sun YH Tsuang MH Chen PW Weng FH Lin 2010 Simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/BMP-2 signaling pathway Nutr Res 30 3 191 199 20417880 10.1016/j.nutres.2010.03.004 1:CAS:528:DC%2BC3cXltF2is7w%3D
31. T Maeda A Matsunuma I Kurahashi T Yanagawa H Yoshida N Horiuchi 2004 Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells J Cell Biochem 92 3 458 471 15156558 10.1002/jcb.20074 1:CAS:528: DC%2BD2cXkvVyhs7o%3D
32. Li X, Cui Q, Kao C, Wang GJ, Balian G (2003) Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. Bone 33(4):652-659 (Pubitemid 37222392)
33. MH Chan TW Mak RW Chiu CC Chow IH Chan CW Lam 2001 Simvastatin increases serum osteocalcin concentration in patients treated for hypercholesterolemia J Clin Endocrinol Metab 86 9 4556 4559 11549708 10.1210/jc.86.9.4556 1:CAS:528:DC%2BD3MXmvFCrsbw%3D (Pubitemid 32848589)
34. Y Uyar Y Baytur U Inceboz BC Demir G Gumuser K Ozbilgin 2009 Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats Maturitas 63 3 261 267 19386450 10.1016/j.maturitas.2009.03.018 1:CAS:528:DC%2BD1MXotFCltrs%3D
35. Z Du J Chen F Yan Y Xiao 2009 Effects of simvastatin on bone healing around titanium implants in osteoporotic rats Clin Oral Implants Res 20 2 145 150 19077150 10.1111/j.1600-0501.2008.01630.x
36. JW Wang SW Xu DS Yang RK Lv 2007 Locally applied simvastatin promotes fracture healing in ovariectomized rat Osteoporos Int 18 12 1641 1650 17622479 10.1007/s00198-007-0412-2 (Pubitemid 47620312)
37. C Hatzigeorgiou JL Jackson 2005 Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis Osteoporos Int 16 8 990 998 15744453 10.1007/s00198-004-1793-0 1:CAS:528:DC%2BD2MXmt12qsr4%3D (Pubitemid 41127110)
38. B Uzzan R Cohen P Nicolas M Cucherat GY Perret 2007 Effects of statins on bone mineral density: a meta-analysis of clinical studies Bone 40 6 1581 1587 17409043 10.1016/j.bone.2007.02.019 1:CAS:528:DC%2BD2sXlsF2nu7s%3D (Pubitemid 46779004)
39. J Yue X Zhang B Dong M Yang 2010 Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials Menopause 17 5 1071 1079 20473231 10.1097/gme.0b013e3181d3e036
40. DC Bauer GR Mundy SA Jamal, et al. 2004 Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials Arch Intern Med 164 2 146 152 14744837 10.1001/archinte.164.2.146 1:CAS:528:DC%2BD2cXhsFWhsLo%3D (Pubitemid 38140400)
41. JL Pérez-Castrillón G Vega L Abad, et al. 2008 Effect of the TNFalpha-308 G/A polymorphism on the changes produced by atorvastatin in bone mineral density in patients with acute coronary syndrome Ann Nutr Metab 53 2 117 121 18997459 10.1159/000170886 (Pubitemid 50327554)
42. Pérez-Castrillón JL, Vega G, Abad L et al. (2009) Atorvastatin and BMD in coronary syndrome. Role of Lys656Asn polymorphism of leptin receptor gene. Endocr J 56(2):221-225
43. LN Bakhireva MR Shainline S Carter, et al. 2010 Synergistic effect of statins and postmenopausal hormone therapy in the prevention of skeletal fractures in elderly women Pharmacotherapy 30 9 879 887 20795843 10.1592/phco.30.9.879 1:CAS:528:DC%2BC3cXhtF2ktr%2FN
44. HA Tanriverdi A Barut S Sarikaya 2005 Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women Eur J Obstet Gynecol Reprod Biol 120 1 63 68 15866088 10.1016/j.ejogrb.2004.08.007 1:CAS:528:DC%2BD2MXjslKgsrk%3D (Pubitemid 40615074)
45. V De Leo G Morgante A la Marca D Lanzetta L Cobellis F Petraglia 2003 Combination of statins and hormone replacement therapy in postmenopausal women is associated with increased bone mineral density Gynecol Endocrinol 17 4 329 332 14503978 (Pubitemid 37083040)
46. H Amuro T Ito R Miyamoto, et al. 2010 Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, function as inhibitors of cellular and molecular components involved in type I interferon production Arthritis Rheum 62 7 2073 2085 20506142 1:CAS:528:DC%2BC3cXht1aqsLzE
47. GA Ferreira AL Teixeira EI Sato 2010 Atorvastatin therapy reduces interferon-regulated chemokine CXCL9 plasma levels in patients with systemic lupus erythematosus Lupus 19 8 927 934 20410153 10.1177/0961203310364400 1:CAS:528:DC%2BC3cXhtVOntrzE
48. EC Jury DA Isenberg C Mauri MR Ehrenstein 2006 Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus J Immunol 177 10 7416 7422 17082661 1:CAS:528:DC%2BD28XhtFGrtrfO (Pubitemid 44715112)
49. H Shimazu K Kinoshita S Hino, et al. 2010 Effect of combining ACE inhibitor and statin in lupus-prone mice Clin Immunol 136 2 188 196 20403731 10.1016/j.clim.2010.03.008 1:CAS:528:DC%2BC3cXos1ynsr8%3D
50. JM Woo Z Lin M Navab, et al. 2010 Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis Arthritis Res Ther 12 3 R93 20482780 10.1186/ar3020
51. T Aprahamian R Bonegio J Rizzo, et al. 2006 Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model J Immunol 177 5 3028 3034 16920939 1:CAS:528: DC%2BD28Xot1CjsLs%3D (Pubitemid 44277819)
52. S Lawman C Mauri EC Jury HT Cook MR Ehrenstein 2004 Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand black/white F1 mice J Immunol 173 12 7641 7646 15585892 1:CAS:528: DC%2BD2cXhtVCqurjP (Pubitemid 39628206)
53. Petri MA, Kiani AN, Post W, Christopher-Stine L, Magder LS (2010) Lupus atherosclerosis prevention study (LAPS). Ann Rheum Dis 70(5):760-765
54. GA Ferreira TP Navarro RW Telles LE Andrade EI Sato 2007 Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial Rheumatology (Oxford) 46 10 1560 1565 10.1093/rheumatology/kem186 1:CAS:528:DC%2BD2sXhsVWgsLrM (Pubitemid 47500570)
55. HM Belmont E Lydon 2005 Avascular necrosis prevention with lipitor in lupus erythematosus Lupus 14 10 869 870 16302686 10.1191/0961203305lu2189xx 1:STN:280:DC%2BD2MnitFCitQ%3D%3D (Pubitemid 41597628)
56. N Del Papa M Cortiana C Vitali, et al. 2008 Simvastatin reduces endothelial activation and damage but is partially ineffective in inducing endothelial repair in systemic sclerosis J Rheumatol 35 7 1323 1328 18528965 1:CAS:528:DC%2BD1cXpslajt74%3D (Pubitemid 352000778)
57. A Abou-Raya S Abou-Raya M Helmii 2007 Statins as immunomodulators in systemic sclerosis Ann NY Acad Sci. 1110 670 680 17911482 10.1196/annals.1423. 070 1:CAS:528:DC%2BD2sXht1GitL3L (Pubitemid 350043056)
58. M Kuwana 2006 Potential benefit of statins for vascular disease in systemic sclerosis Curr Opin Rheumatol 18 6 594 600 17053504 10.1097/01.bor.0000245720.02512.3e 1:CAS:528:DC%2BD28XhtV2rsrfL (Pubitemid 44607412)
59. N Louneva G Huaman J Fertala SA Jiménez 2006 Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin Arthritis Rheum 54 4 1298 1308 16575855 10.1002/art.21723 1:CAS:528:DC%2BD28XksVyhtbs%3D (Pubitemid 43672943)
60. A Abou-Raya S Abou-Raya M Helmii 2008 Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers J Rheumatol 35 9 1801 1808 18709692 1:CAS:528:DC%2BD1cXhtFyqtbvE
61. M Kuwana Y Okazaki J Kaburaki 2009 Long-term beneficial effects of statins on vascular manifestations in patients with systemic sclerosis Mod Rheumatol 19 5 530 535 19590932 10.1007/s10165-009-0199-4 1:CAS:528: DC%2BD1MXht1Ggtr7J
62. T Simopoulou KN Malizos L Poultsides A Tsezou 2010 Protective effect of atorvastatin in cultured osteoarthritic chondrocytes J Orthop Res 28 1 110 115 19623662 1:CAS:528:DC%2BC3cXkvFOisA%3D%3D
63. FM Sverdrup MP Yates LE Vickery, et al. 2010 Protein geranylgeranylation controls collagenase expression in osteoarthritic cartilage Osteoarthritis Cartilage 18 7 948 955 20417291 10.1016/j.joca.2010.03.015
64. I Litinsky I Golan M Yaron I Yaron D Caspi O Elkayam 2009 Simvastatin induces apoptosis of fibroblast-like synoviocytes Open Rheumatol J. 3 35 40 19771181 10.2174/1874312900903010035 1:CAS:528:DC%2BD1MXhtFGntLrI
65. PE Lazzerini PL Capecchi F Nerucci, et al. 2004 Simvastatin reduces MMP-3 level in interleukin 1beta stimulated human chondrocyte culture Ann Rheum Dis 63 7 867 869 15194586 10.1136/ard.2003.009746 1:CAS:528:DC%2BD2cXmsVKqurY%3D (Pubitemid 38850462)
66. Rabinowitz JL, Gregg JR, Nixon JE, Schumacher HR (1979) Lipid composition of the tissues of the human knee joints. I-Observations in normal joints (articular cartilage, meniscus, ligaments, synovial fluid, synovium, intra-articular fat pad and bone marrow). Clin Orthop Relat Res (143):260-265 (Pubitemid 10187833)
67. JW Pritchett 2007 Statins and dietary fish oils improve lipid composition in bone marrow and joints Clin Orthop Relat Res. 456 233 237 17496750 (Pubitemid 46662423)
68. Y Akasaki S Matsuda K Nakayama S Fukagawa H Miura Y Iwamoto 2009 Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation Osteoarthritis Cartilage 17 2 235 243 18672387 10.1016/j.joca.2008.06.012 1:STN:280:DC%2BD1M7itlWksA%3D%3D
69. Akasaki Y, Matsuda S, Iwamoto Y (2009) Progress of research in osteoarthritis. The anti-inflammatory effects of intra-articular injected statin on experimental osteoarthritis. Clin Calcium 19(11):1653-1662
70. López-Pedrera C, Ruiz-Limón P, Aguirre MA et al. (2010) Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome. Ann Rheum Dis 70(4):675-682
71. P Jajoria V Murthy E Papalardo Z Romay-Penabad C Gleason SS Pierangeli 2009 Statins for the treatment of antiphospholipid syndrome? Ann N Y Acad Sci 1173 736 745 19758223 10.1111/j.1749-6632.2009.04815.x 1:CAS:528: DC%2BD1MXhtlCnt73I
72. PL Meroni E Raschi C Testoni, et al. 2001 Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype Arthritis Rheum 44 12 2870 2878 11762948 10.1002/1529-0131(200112)44:12<2870::AID- ART475>3.0.CO;2-Y 1:CAS:528:DC%2BD38XislCltQ%3D%3D (Pubitemid 34016207)
73. P Redecha CW Franzke W Ruf N Mackman G Girardi 2008 Neutrophil activation by the tissue factor/factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome J Clin Invest 118 10 3453 3461 18802482 1:CAS:528:DC%2BD1cXht1ChsrjK
74. DE Ferrara X Liu RG Espinola, et al. 2003 Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model Arthritis Rheum 48 11 3272 3279 14613293 10.1002/art.11449 1:CAS:528:DC%2BD3sXpvVygtbk%3D (Pubitemid 37409342)
75. Vasiuk IuA, Perlamutrov IuN, Shkol'nik MN, Shkol'nik EL (2010) Possibilities of atorvastatin in complex management of extensive psoriasis in patients with arterial hypertension. Kardiologiia. 50(3):37-46
76. M Naseri A Hadipour M Sepaskhah MR Namazi 2010 The remarkable beneficial effect of adding oral simvastatin to topical betamethasone for treatment of psoriasis: a double-blind, randomized, placebo-controlled study Niger J Med 19 1 58 61 20232758 1:STN:280:DC%2BC3c7ovVSksg%3D%3D
77. A Hamaoka K Hamaoka T Yahata, et al. 2010 Effects of HMG-CoA reductase inhibitors on continuous post-inflammatory vascular remodeling late after Kawasaki disease J Cardiol 56 2 245 253 20678900 10.1016/j.jjcc.2010.06.006
78. SM Huang KP Weng JS Chang, et al. 2008 Effects of statin therapy in children complicated with coronary arterial abnormality late after kawasaki disease: a pilot study Circ J 72 10 1583 1587 18758088 10.1253/circj.CJ-08-0121 1:CAS:528:DC%2BD1cXht1KqtrjJ
79. JC van Denderen MJ Peters VP van Halm, et al. 2006 Statin therapy might be beneficial for patients with ankylosing spondylitis Ann Rheum Dis 65 5 695 696 16219702 10.1136/ard.2005.044503
80. MT Inanc N Kalay T Heyit, et al. 2010 Effects of atorvastatin and lisinopril on endothelial dysfunction in patients with Behçet's disease Echocardiography 27 8 997 1003 20545993 10.1111/j.1540-8175.2010.01180.x
81. T Hashimoto Y Toya M Kihara, et al. 2008 Behçet's disease complicated by IgA nephropathy with nephrotic syndrome Clin Exp Nephrol 12 3 224 227 18224274 10.1007/s10157-008-0029-6
82. R ten Cate PH Nibbering RG Bredius 2004 Therapy-refractory systemic juvenile idiopathic arthritis successfully treated with statins Rheumatology (Oxford) 43 7 934 935 10.1093/rheumatology/keh194 1:STN:280: DC%2BD2czht1ShsA%3D%3D (Pubitemid 38996973)
83. RS Rosenson 2004 Current overview of statin-induced myopathy Am J Med 116 6 408 416 15006590 10.1016/j.amjmed.2003.10.033 1:CAS:528:DC%2BD2cXhvFalt7k%3D (Pubitemid 38299486)
84. L Sailler C Pereira A Bagheri, et al. 2008 Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study Ann Rheum Dis 67 5 614 619 17768174 10.1136/ard.2007.075523 1:STN:280: DC%2BD1c3ksVartg%3D%3D (Pubitemid 351571923)
85. D Sen ED Rosenstein N Kramer 2010 ANCA-positive vasculitis associated with simvastatin/ezetimibe: expanding the spectrum of statin-induced autoimmunity? Int J Rheum Dis 13 3 e29 e31 20704607 10.1111/j.1756-185X.2010. 01481.x
86. M Haroon J Devlin 2008 A case of ANCA-associated systemic vasculitis induced by atorvastatin Clin Rheumatol 27 Suppl 2 S75 S77 18839266 10.1007/s10067-008-1020-z
87. B Noel 2007 Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review J Eur Acad Dermatol Venereol 21 1 17 24 17207162 10.1111/j.1468-3083.2006.01838.x 1:STN:280:DC%2BD2s%2FhtFakug%3D%3D (Pubitemid 44942318)
88. V Goëb N Guillemant O Vittecoq X Le Loët 2004 Cerivastatin-induced polymyalgia rheumatica-like illness Clin Rheumatol 23 2 179 15045638 10.1007/s10067-003-0772-8 (Pubitemid 38559194)
89. M Yamamoto M Ikeda H Kodama S Sano 2008 Transition of psoriasiform drug eruption to psoriasis de novo evidenced by histopathology J Dermatol 35 11 732 736 19120769 10.1111/j.1346-8138.2008.00558.x
90. AE Adams AM Bobrove AC Gilliam 2010 Statins and "chameleon- like" cutaneous eruptions: simvastatin-induced acral cutaneous vesiculobullous and pustular eruption in a 70-year-old man J Cutan Med Surg 14 5 207 211 20868617
91. Adams AE, Bobrove AM, Gilliam AC (2010) Statins inhibit the antirheumatic effects of rituximab in rheumatoid arthritis: results from the Dutch rheumatoid arthritis monitoring (DREAM) registry. Ann Rheum Dis 70(5):877-878
92. Aronow C, Diamond B. A double blind, placebo controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis. National Institute of Allergy and Infectious Diseases. Clinialtrials gov NCT00302952
93. Ming Li EK. Effects of HMG-coA reductase inhibitor on progression of carotid intima-media thickness and arterial stiffness in rheumatoid arthritis. The Chinese University of Hong Kong. Clinicaltrial gov NCT00555230
94. Ansell BJ. Effects of atorvastatin on disease activity and HDL cholesterol anti-inflammatory properties in patients with rheumatoid arthritis. The University of California, Los Angeles. Clinicatrial gov NCT00356473
95. Pfizer, Inc. Phase 2 study of the effects of open-label CP-690,550 and double-blind atorvastatin on lipids in patients with active rheumatoid arthritis. Clinicaltrial gov NCT01059864
96. Abdou NI. Statins and Lupus: effects of statins on clinical lupus parameters, serological markers and toll-like receptors. St. Luke's Hospital. Clinicaltrial gov NCT00519363
97. Lai NS. An open labeled pilot study of atorvastatin in systemic lupus erythematosus. Buddhist Dalin Chi Tzu General Hospital. Clinicaltrial gov NCT00432354
98. Schanberg LE. A multicenter, randomized, double-blind, placebo-controlled study to test the safety and efficacy of lipitor (atorvastatin) in reducing the progression of carotid IMT in early childhood SLE. Duke University. Clinicaltrial gov NCT00065806
99. Belmont HM. Atorvastatin to prevent avascular necrosis of bone in steroid treated exacerbated systemic lupus erythematosus. New York University. Clinicaltrial gov NCT00412841
100. Erkan D, Pierangeli S. Effects of fluvastatin on proinflammatory and prothrombotic markers in antiphospholipid syndrome patients. Hospital for Special Surgery. Clinicaltrial gov NCT00674297